-
-
-
-
-
-
-
Baidu, ASML, furniture stocks rise; Outlook Therapeutics sinks
-
-
-
-
-
-
-
Outlook Therapeutics plans BLA resubmission after FDA meeting
-
-
-
-
-
-
-
Outlook Therapeutics (OTLK) Appoints Bob Jahr as CEO
-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on Outlook Therapeutics Incs. (OTLK)
-
-
-
-
-
-
-
Outlook Therapeutics (OTLK) Reports Complete Twelve Week Efficacy and Safety Results of NORSE EIGHT Clinical Trial
-
-
-
-
-
-
-
Outlook Therapeutics Incs. (OTLK) PT Lowered to $9 at BTIG
-
-
-
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

